α-Synucleinopathy phenotypes

Parkinsonism and Related Disorders

Volumn 20, Issue SUPPL.1, 2014, Pages

  McCann, Heather ^a   Stevens, Claire H ^a,b   Cartwright, Heidi ^a   Halliday, Glenda M ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Synuclein; Dementia with Lewy bodies; Multiple system atrophy; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

ALPHA SYNUCLEINOPATHY; ARTICLE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; GLIA CELL; HUMAN; NERVE DEGENERATION; NEUROAXONAL DYSTROPHY; NEUROPATHOLOGY; PARKINSON DISEASE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RARE DISEASE; SHY DRAGER SYNDROME;

DEMENTIA WITH LEWY BODIES; MULTIPLE SYSTEM ATROPHY; PARKINSON'S DISEASE; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; HUMANS; LEWY BODY DISEASE; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PHENOTYPE;

EID: 84887921166     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/S1353-8020(13)70017-8     Document Type: Article

References (30)

1. Jakes R, Spillantini MG, Goedert M Identification of two distinct synucleins from human brain. FEBS Lett 1994, 345:27-32.
2. Uversky VN A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J Biomol Struct Dyn 2003, 21:211-234.
3. Gibb WR, Lees AJ A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1988, 38:1402-1406.
4. Parkkinen L, Pirttila T, Alafuzoff I Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 2008, 115:399-407.
5. Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 2012, 27:617-626.
6. Gelb DJ, Oliver E, Gilman S Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
7. Bonnet AM, Jutras MF, Czernecki V, Corvol JC, Vidailhet M Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinson Dis 2012, 2012:198316.
8. McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D Characteristics of executive function impairment in Parkinson's disease patients without dementia. J Int Neuropsychol Soc 2010, 16:268-277.
9. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008, 23:837-844.
10. van Rooden S, Heiser W, Kok J, Verbaan D, van Hilten J, Marinus J The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord 2010, 25:969-978.
11. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
12. Halliday GM, McCann H The progression of pathology in Parkinson's disease. Ann N Y Acad Sci 2010, 1184:188-195.
13. Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ A clinico-pathological study of subtypes in Parkinson's disease. Brain 2009, 132:2947-2957.
14. Lashley T, Holton JL, Gray E, Kirkham K, O'Sullivan SS, Hilbig A, et al. Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients. Acta Neuropathol 2008, 115:417-425.
15. Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C, et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?. Brain 2011, 134:1493-1505.
16. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
17. Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol 2010, 257:359-366.
18. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
19. Hamilton RL Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 2000, 10:378-384.
20. Kraybill ML, Larson EB, Tsuang DW, Teri L, McCormick WC, Bowen JD, et al. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology 2005, 64:2069-2073.
21. Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 2007, 69:356-359.
22. Uchikado H, Lin WL, DeLucia MW, Dickson DW Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 2006, 65:685-697.
23. Lopez OL, Becker JT, Sweet RA, Martin-Sanchez FJ, Hamilton RL Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology 2006, 67:660-665.
24. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
25. O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008, 131:1362-1372.
26. Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 2010, 133:2382-2393.
27. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992, 55:1009-1013.
28. Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, et al. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 2012, 38:4-24.
29. Jellinger KA, Seppi K, Wenning GK Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 2005, 20(Suppl 12):S29-S36.
30. Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004, 127:2657-2671.